Creative Commons License

Except where otherwise noted, the content provided on this site is licensed under a Creative Commons Attribution-NoDerivs 2.5 License.

News Detail

E-mail this page Email a link to this Page   

Worldwide Electronic Lab Notebooks Industry Symposium Co-Sponsored by Synthematix, Symyx IntelliChem & Waters, Apr 4-5 in Boston

The much anticipated Electronic Laboratory Notebooks Summit, scheduled to take place on April 4-5, 2005 in Boston, MA, is a two-day learning forum that will feature ground-breaking information pivotal to your ELN management strategy and will also consist of lectures that will reflect on how the implementation of ELNs are increasing R&D productivity & driving innovation in drug discovery. This event offers pre-conference workshops, networking capacities, insights from leading suppliers and the most up-to-date resourceful best-practice tools for both current and prospective ELN users. You will be exposed to a stellar lineup of speakers and panelists to address the most contemporary topics and engage in active discussion with the audience, according to Strategic Research Institute.

Approximately one hundred individuals from pharmaceutical companies, biotechs, R&D companies, ELN pioneers, leading suppliers, and innovative developers will be in attendance. Pre-conference workshops on R&D Automation Futures are offered by Rich Lysakowski of CENSA, and ELN Implementation Strategies by Simon Coles of Amphora Research Systems.   

Complete list of presenters includes: Amphora Research Systems, Array BioPharma, Atrium Research & Consulting, Biovitrum AB, Boehringer Ingelheim, Boston University, Bristol-Myers Squibb, CENSA, Eisai Research Institute, GERA, Heller Ehrman White & McAuliffe LLP, Kalexsyn, Memory Pharmaceuticals, Millennium Pharmaceuticals, Oxford BioMedica, Pfizer Global R&D, Rohm and Haas, Symyx IntelliChem & Synthematix, Inc.

To view and/or register for the conference, please visit .


Posted by: limsfinder on Mar 25,05| Profile| ELN - Electronic Lab Notebook


signupor loginto post a comment.

Enter New Comments: